PhRMA宣布两项领导层人事任命:Kristi Way出任高级执行副总裁兼战略与运营负责人,此前任职于Moelis & Company,并曾担任Eric Cantor的幕僚长;Michael Woody晋升为执行副总裁,负责联邦倡导事务,拥有逾20年联邦卫生政策经验。两人将共同推进PhRMA使命,促进患者获得药物并推动美国创新。
Our mandate is to advance and protect the American biopharmaceutical industry while championing policies that help patients access the medicines they need. To accomplish these goals, we need to have a strong, decisive leadership team. We're pleased to announce two important additions to PhRMA's leadership team.
Kristi Way has joined PhRMA as Senior Executive Vice President, Head of Strategy and Operations. Kristi brings decades of leadership experience across government, business and strategic operations, most recently at Moelis & Company. She previously served as Chief of Staff and Senior Advisor to Eric Cantor during his tenure in Congress.
Michael Woody has been promoted to Executive Vice President, Federal Advocacy. Mike brings more than 20 years of experience in federal health policy, including as a senior health policy advisor to Former Senator Tom Harkin (D-IA) on the Senate HELP Committee. Since returning to PhRMA in 2022, he has played a key role in strengthening our bipartisan engagement on Capitol Hill and advancing policies that support patients and American innovation.
Together, Mike and Kristi will play important roles in advancing PhRMA’s mission providing patients access to life saving and life changing medicines while in pursuit of more American innovation.
Congratulations Kristi and Mike!
来源:PhRMA · x.com